BELFB vs NBIX · P/E 31, $1.28B cap vs P/E 45, rev $1.77B
Bel Fuse B Inc (BELFB) versus Neurocrine Biosciences Inc (NBIX) — a side-by-side from cached financials, not a winner call.
Bel Fuse B Inc (BELFB) is a electronic components company listed on US.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
BELFB does not have a complete income-statement cache yet.
Latest reported NBIX revenue for 2026-06-30 was $1.77B. Net income was $342.3M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
BELFB currently screens at market cap $1.28B and trailing P/E 30.9. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Not investment advice. Open the BELFB and NBIX stock pages for the full models.
Not investment advice.